Guided Therapeutics
(OTC) GTHP
Guided Therapeutics Financials at a Glance
Market Cap
$22.57M
Revenue (TTM)
$178.00K
Net Income (TTM)
$2.63M
EPS (TTM)
$-0.04
P/E Ratio
-6.99
Dividend
$0.00
Beta (Volatility)
0.12 (Low)
Dividend
$0.00
Beta (Volatility)
0.12 (Low)
Price
$0.27
Volume
12,700
Open
$0.26
Price
$0.27
Volume
12,700
Open
$0.26
Previous Close
$0.27
Daily Range
$0.26 - $0.27
52-Week Range
$0.06 - $0.54
Dividend
$0.00
Beta (Volatility)
0.12 (Low)
Price
$0.27
Volume
12,700
Open
$0.26
Previous Close
$0.27
Daily Range
$0.26 - $0.27
52-Week Range
$0.06 - $0.54
GTHP News
GTHP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Guided Therapeutics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
7
CEO
Mark L. Faupel, PhD
Website
www.guidedinc.comHeadquarters
Norcross, GA 30092, US
GTHP Financials
Key Financial Metrics (TTM)
Gross Margin
34%
Operating Margin
-12%
Net Income Margin
-15%
Return on Equity
0%
Return on Capital
39%
Return on Assets
-3%
Earnings Yield
-14.31%
Dividend Yield
0.00%
Payout Ratio
-7.86%
Stock Overview
Market Cap
$22.57M
Shares Outstanding
83.60M
Volume
12.70K
Short Interest
0.00%
Avg. Volume
17.25K
Financials (TTM)
Gross Profit
$2.00K
Operating Income
$2.11M
EBITDA
$1.94M
Operating Cash Flow
$1.12M
Capital Expenditure
$0.00
Free Cash Flow
$1.12M
Cash & ST Invst.
$388.00K
Total Debt
$2.16M
Guided Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$60.00K
N/A
Gross Profit
$8.00K
+133.3%
Gross Margin
13.33%
N/A
Market Cap
$22.57M
N/A
Market Cap/Employee
$5.64M
N/A
Employees
4
N/A
Net Income
$742.00K
-13.5%
EBITDA
$586.00K
-12.3%
Quarterly Fundamentals
Net Cash
$2.33M
-8.4%
Accounts Receivable
$6.00K
+200.0%
Inventory
$583.00K
-8.3%
Long Term Debt
$79.00K
-44.4%
Short Term Debt
$2.34M
+6.2%
Return on Assets
-2.91%
N/A
Return on Invested Capital
39.43%
N/A
Free Cash Flow
$279.00K
+41.0%
Operating Cash Flow
$277.00K
+41.4%